Biosafety Aspects of Molecular Farming in Plants

  • Commandeur U
  • Twyman R
  • 46


    Mendeley users who have this article in their library.
  • 3


    Citations of this article.


Molecular farming in plants provides an inexpensive and convenient way to produce biopharmaceutical molecules and other valuable proteins on a large scale. Proof of principle has been demonstrated for a large number of recombinant human proteins, subunit vaccines and antibodies, and detailed cost evaluations have been described for the production of technical proteins in maize. In terms of biosafety, plants have several advantages over traditional production systems, such as the absence of endotoxins, human pathogens and oncogenic DNA sequences. However, other biosafety concerns remain to be addressed. These not only reflect the quality and safety of the final product, but also the wider effects of molecular farming on health and the environment. In this review we discuss the technological basis of molecular farming in plants and identify potential biosafety risks: transgene spread in the environment, recombinant protein accumulation in the ecosystem, contamination of food and feed chains with transgenes and their products, and product quality and safety.

Author-supplied keywords

  • Biosafety aspects
  • Combating the vertical spread of transgenes
  • Molecular farming in plants
  • Transgene spread
  • Unintended exposure to recombinant proteins

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Ulrich Commandeur

  • Richard M. Twyman

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free